Matuo, Hidemasa(Graduate School of Medicine, Department of Human Health Sciences) | Activity Database on Education and Research, Kyoto University

Matuo, Hidemasa

Graduate School of Medicine, Department of Human Health Sciences Associate Professor

Last Updated :2025/05/02

Basic Information

Faculty

医学部

Email Address

Email Address
matuo.hidemasa.7skyoto-u.ac.jp

Professional Memberships

日本臨床検査学教育協議会

Japanese Association of Medical Technologists

Japanese Society of Laboratory Medicine

Japanese Society of Hematology

Japan Society of Ultrasonics in Medicine

Japanese Cancer Association

日本臨床検査同学院

Academic Degree

修士（人間健康科学）(京都大学)

博士（人間健康科学）(京都大学)

Academic Resume (Undergraduate School/Majors)

京都大学, 医学部保健学科検査技術科学専攻, 卒業

High School

High School
京都教育大学附属高等学校

Research History

From Apr. 2024, To Present
京都大学大学院医学研究科, 人間健康科学系専攻, 准教授

From Apr. 2018, To Mar. 2024
京都大学大学院医学研究科, 人間健康科学系専攻, 助教

From Aug. 2013, To Mar. 2018
京都大学医学部附属病院, 検査部, 臨床検査技師

From Apr. 2013, To Jul. 2013
京都大学医学部附属病院, 検査部, 特定臨床検査技師

Profile

Profile
Medical Technologist, JSUM Registered Medical Sonographer, Molecular Analysis Specialist (CLMJ), Technologist in Cardiology (CLMJ), International Medical Laboratory Scientist, MLS(ASCPi)CM

Last Updated :2025/05/02

Research

Research Topics, Overview of the research

Research Topics
1. Investigation of novel examinations and treatment strategies for acute myeloid leukemia.
2. Establishment of the assessment method for rheumatoid arthritis and coexisting diseases using ultrasound.
Overview of the research
I am investigating novel examinations and treatment strategies for acute myeloid leukemia using clinical samples, cell lines, and mouse models.
As a certified sonographer, I am also studying to establish improved assessment methods for rheumatoid arthritis and coexisting diseases using ultrasound.
Both studies are proceeding through collaboration with each department of Kyoto University Hospital (Department of Laboratory Medicine, Pediatrics, Hematology, Therapeutic Oncology, Diagnostic Pathology, Rheumatoid Arthritis Center, Respiratory Medicine, Diagnostic Imaging and Nuclear Medicine, etc.).

Research Interests

Clinical examination

Hematological malignancies

Genomic analysis

Prognostic factors

Medical ultrasound

Rheumatoid arthritis

Research Areas

Life sciences, Hematology and oncology

Life sciences, Tumor diagnostics and therapeutics

Life sciences, Medical systems

Papers

Donor-derived CD8-predominant T cells in human graft-versus-host disease of the brain after allogeneic transplantation.
Nishikubo M, Matsuo H, Manabe S, Ota K, Ishii J, Hiramoto N, Hara S, Kondo T, Ishikawa T
Br J Haematol. 2024 May 1. Epub ahead of print., 2024, Peer-reviewed

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.
Iyoda S, Yoshida K, Shoji K, Ito N, Tanaka M, Nannya Y, Yamato G, Tsujimoto S, Shiba N, Hayashi Y, Shiozawa Y, Shiraishi Y, Chiba K, Okada A, Tanaka H, Miyano S, Koga Y, Goto H, Moritake H, Terui K, Ito E, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Takita J, Nishikori M, Adachi S, Ogawa S, Matsuo H
Leukemia. 2024 Apr 18. Epub ahead of print., 2024, Peer-reviewed, Last author, Corresponding author

Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.
Sato T, Yoshida K, Toki T, ..., Sato A, Koh K, Karakawa S, Kobayashi M, Hara J, Taneyama Y, Imai C, Hasegawa D, Fujita N, Yoshitomi M, Iwamoto S, Yamato G, Saida S, Kiyokawa N, Deguchi T, Ito M, Matsuo H, Adachi S, Hayashi Y, Taga T, Moriya Saito A, Horibe K, Watanabe K, Tomizawa D, Miyano S, Takahashi S, Ogawa S, Ito E
Blood. 2024 Mar 21. Epub ahead of print., 2024, Peer-reviewed

Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.
Matsuo H, Inagami A, Ito Y, Ito N, Iyoda S, Harata Y, Higashitani M, Shoji K, Tanaka M, Noura M, Mikami T, Kato I, Takita J, Nakahata T, Adachi S
Commun Biol. 2024 Jan 24;7(1):123., Jan. 2024, Peer-reviewed, Lead author, Corresponding author

Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M, Matsuo H, Yasuda T, Tsuzuki S, Kiyoi H, Hayakawa F
Oncogene. 2024 Feb;43(6):447-456., Feb. 2024, Peer-reviewed

Label-free cell detection of acute leukemia using ghost cytometry.
Kawamura Y, Nakanishi K, Murata Y, Teranishi K, Miyazaki R, Toda K, Imai T, Kajiwara Y, Nakagawa K, Matsuo H, Adachi S, Ota S, Hiramatsu H
Cytometry A. 2024 Mar;105(3):196-202., Mar. 2024, Peer-reviewed

TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.
Hara Y, Shiba N, Yoshida K, Yamato G, Kaburagi T, Shiraishi Y, Ohki K, Shiozawa Y, Kawamura M, Kawasaki H, Sotomatsu M, Takizawa T, Matsuo H, Shimada A, Kiyokawa N, Tomizawa D, Taga T, Ito E, Horibe K, Miyano S, Adachi S, Taki T, Ogawa S, Hayashi Y
Genes Chromosomes Cancer. 2023 Jul;62(7):412-422., Jul. 2023, Peer-reviewed

RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.
Mikami M, Masuda T, Kanatani T, Noura M, Umeda K, Hiramatsu H, Kubota H, Daifu T, Iwai A, Hattori EY, Furuichi K, Takasaki S, Tanaka S, Matsui Y, Matsuo H, Hirata M, Kataoka TR, Nakahata T, Kuwahara Y, Iehara T, Hosoi H, Imai Y, Takita J, Sugiyama H, Adachi S, Kamikubo Y
Mol Cells. 2022 Dec 31;45(12):886-895., Dec. 2022, Peer-reviewed

A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice.
Hattori EY, Masuda T, Mineharu Y, Mikami M, Terada Y, Matsui Y, Kubota H, Matsuo H, Hirata M, Kataoka TR, Nakahata T, Ikeda S, Miyamoto S, Sugiyama H, Arakawa Y, Kamikubo Y
Commun Biol. 2022 Sep 9;5(1):939., Sep. 2022, Peer-reviewed

Machine learning-based prediction of relapse in rheumatoid arthritis patients using data on ultrasound examination and blood test.
Matsuo H, Kamada M, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Hashimoto M, Tanaka M, Ito H, Fujii Y
Sci Rep. 2022 May 4;12(1):7224., May 2022, Peer-reviewed, Lead author, Corresponding author

Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.
Kaburagi T, Yamato G, Shiba N, Yoshida K, Hara Y, Tabuchi K, Shiraishi Y, Ohki K, Sotomatsu M, Arakawa H, Matsuo H, Shimada A, Taki T, Kiyokawa N, Tomizawa D, Horibe K, Miyano S, Taga T, Adachi S, Ogawa S, Hayashi Y
Haematologica. 2022 Mar 1;107(3):583-592., Mar. 2022, Peer-reviewed

Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA.
Morimoto S, Kondo T, Taya T, Matsuo H, Teramoto Y, Mizumoto C, Kanda J, Yamashita K, Takaori-Kondo A
Ann Hematol. 2022 May;101(5):1129-1132., May 2022, Peer-reviewed

RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.
Masuda T, Maeda S, Shimada S, Sakuramoto N, Morita K, Koyama A, Suzuki K, Mitsuda Y, Matsuo H, Kubota H, Kato I, Tanaka K, Takita J, Hirata M, Kataoka TR, Nakahata T, Adachi S, Hirai H, Mizuta S, Naka K, Imai Y, Kimura S, Sugiyama H, Kamikubo Y
Cancer Sci. 2022 Feb;113(2):529-539., Feb. 2022, Peer-reviewed

Albendazole Induces the Terminal Differentiation of Acute Myeloid Leukemia Cells to Monocytes by Stimulating the KLF4-DPYSL2A Axis.
Noura M, Morita K, Kiyose H, Okuno Y, Matsuo H, Koyama A, Nishinaka-Arai Y, Kamikubo Y, Adachi S
Br J Haematol. 2021 Aug;194(3):598-603., Aug. 2021, Peer-reviewed

Efficacy of a combination therapy targeting CDK4/6 and autophagy in a mouse xenograft model of t(8;21) acute myeloid leukemia.
Matsuo H, Nakatani K, Harata Y, Higashitani M, Ito Y, Inagami A, Noura M, Nakahata T, Adachi S
Biochem Biophys Rep. 2021 Aug 13;27:101099., Aug. 2021, Peer-reviewed, Lead author

Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in pediatric acute myeloid leukemia especially showing RUNX1-RUNX1T1 transcripts.
Sasaki K, Tsujimoto S, Miyake M, Uchiyama Y, Ikeda J, Yoshitomi M, Shimosato Y, Tokumasu M, Matsuo H, Yoshida K, Ohki K, Kaburagi T, Yamato G, Hara Y, Takeuchi M, Kinoshita A, Tomizawa D, Taga T, Adachi S, Tawa A, Horibe K, Hayashi Y, Matsumoto N, Ito S, Shiba N
Br J Haematol. 2021 Jul;194(2):414-422., Jul. 2021, Peer-reviewed

Positive rate and prognostic significance of the superb microvascular imaging signal in joints of rheumatoid arthritis patients in remission with normal C-reactive protein levels and erythrocyte sedimentation rates
Matsuo H, Tabuchi Y, Yukimatsu R, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Nakabo S, Tsuji H, Nakajima T, Hashimoto M, Ito H, Morinobu A, Fujii Y
J Med Ultrason (2001). 2021 Jul;48(3):353-359., Jul. 2021, Peer-reviewed, Lead author, Corresponding author

RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axis.
Kubota H, Masuda T, Noura M, Furuichi K, Matsuo H, Hirata M, Kataoka TR, Hiramatsu H, Yasumi T, Nakahata T, Imai Y, Takita J, Adachi S, Sugiyama H, Kamikubo Y
EJHaem. 2021;1-10., Mar. 2021, Peer-reviewed

Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells.
Nakatani K*, Matsuo H*, Harata Y, Higashitani M, Koyama A, Noura M, Nishinaka-Arai Y, Kamikubo Y, Adachi S, *equal contribution.
Int J Hematol. 2021 Feb;113(2):243-253., Feb. 2021, Peer-reviewed, Lead author

Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression.
Matsuo H, Wakita T, Hiramatsu H, Ohmori K, Kodama K, Nakatani K, Kamikubo Y, Iwamoto S, Kondo T, Takaori-Kondo A, Takita J, Tomizawa D, Taga T, Adachi S
Br J Haematol. 2021 Jan;192(1):e7-e11., Jan. 2021, Peer-reviewed, Lead author

Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.
Noura M, Morita K, Kiyose H, Matsuo H, Nishinaka-Arai Y, Kurokawa M, Kamikubo Y, Adachi S
Sci Rep. 2020 Nov 20;10(1):20245., Nov. 2020, Peer-reviewed

Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Matsuo H, Yoshida K, Nakatani K, Harata Y, Higashitani M, Ito Y, Kamikubo Y, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Miyano S, Meggendorfer M, Haferlach C, Ogawa S, Adachi S
Blood Adv. 2020 Oct 13;4(19):4623-4631., Oct. 2020, Peer-reviewed, Lead author
Access this paper :

TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells.
Noura M; Matsuo H; Koyama A; Adachi S; Masutani H
FEBS Open Bio. 2020 Aug;10(8):1532-1541., Aug. 2020, Peer-reviewed
Access this paper :

EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.
Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H.
Haematologica. 2020 Aug;105(8):2118-2129., Aug. 2020, Peer-reviewed

Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis.
Matsuo H; Imamura A; Shimizu M; Inagaki M; Tsuji Y; Nakabo S; Hashimoto M; Ito H; Tanaka S; Mimori T; Fujii Y
J Med Ultrason (2001). 2020 Jan;47(1):131-138., Jan. 2020, Peer-reviewed, Lead author, Corresponding author

Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.
Shiba N; Yoshida K; Hara Y; Yamato G; Shiraishi Y; Matsuo H; Okuno Y; Chiba K; Tanaka H; Kaburagi T; Takeuchi M; Ohki K; Sanada M; Okubo J; Tomizawa D; Taki T; Shimada A; Sotomatsu M; Horibe K; Taga T; Adachi S; Tawa A; Miyano S; Ogawa S; Hayashi Y
Blood Adv. 2019 Oct 22;3(20):3157-3169., Oct. 2019, Peer-reviewed

Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.
Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
Blood Adv. 2018 Nov 13;2(21):2879-2889., Nov. 2018, Peer-reviewed, Lead author

Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification.
Matsuo H; Handa T; Tsuchiya M; Kubo T; Yoshizawa A; Nakayama Y; Shiga S; Hitomi T; Adachi S; Date H; Hirai T; Ichiyama S
Intern Med. 2018 Jun 1;57(11):1631-1636., Jun. 2018, Peer-reviewed, Lead author

Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia.
Matsuo H; Iijima-Yamashita Y; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int. 2018 Jan;60(1):41-46., Jan. 2018, Peer-reviewed, Lead author

Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y*; Matsuo H*; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K; *equal contribution.
Pediatr Int. 2018 Jan;60(1):47-51., Jan. 2018, Peer-reviewed, Lead author

Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.
Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y
Sci Rep. 2017 Nov 30;7(1):16604., Nov. 2017, Peer-reviewed
Access this paper :

Fludarabine, cytarabine, G-CSF and idarubicin for children with relapsed AML.
Nakayama H; Tomizawa D; Tanaka S; Iwamoto S; Shimada A; Saito AM; Yamashita Y; Moritake H; Terui K; Taga T; Matsuo H; Kosaka Y; Koh K; Hosoi H; Kurosawa H; Isoyama K; Horibe K; Mizutani S; Adachi S
Pediatr Int. 2017 Oct;59(10):1046-1052., Oct. 2017, Peer-reviewed

Purification of leukemic blast cells from blood smears using laser microdissection.
Matsuo H; Shiga S; Imai T; Kamikubo Y; Toki T; Terui K; Ito E; Adachi S
Int J Hematol. 2017 Jul;106(1):55-59., Jul. 2017, Peer-reviewed, Lead author

Genetic regulation of the RUNX transcription factor family has antitumor effects.
Morita K; Suzuki K; Maeda S; Matsuo A; Mitsuda Y; Tokushige C; Kashiwazaki G; Taniguchi J; Maeda R; Noura M; Hirata M; Kataoka T; Yano A; Yamada Y; Kiyose H; Tokumasu M; Matsuo H; Tanaka S; Okuno Y; Muto M; Naka K; Ito K; Kitamura T; Kaneda Y; Liu PP; Bando T; Adachi S; Sugiyama H; Kamikubo Y
J Clin Invest. 2017 Jun 30;127(7):2815-2828., Jun. 2017, Peer-reviewed

CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Pediatr Blood Cancer. 2016 Aug;63(8):1394-9., Aug. 2016, Peer-reviewed, Lead author

Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria.
Matsuo H; Itoh H; Kitamura N; Kamikubo Y; Higuchi T; Shiga S; Ichiyama S; Kondo T; Takaori-Kondo A; Adachi S
Biochem Biophys Res Commun. 2015 Aug 14;464(1):94-9., Aug. 2015, Peer-reviewed, Lead author

Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains.
Itoh H*; Matsuo H*; Kitamura N; Yamamoto S; Higuchi T; Takematsu H; Kamikubo Y; Kondo T; Yamashita K; Sasada M; Takaori-Kondo A; Adachi S; *equal contribution.
J Leukoc Biol. 2015 Jul;98(1):107-17., Jul. 2015, Peer-reviewed, Lead author

The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.
Matsuo H; Goyama S; Kamikubo Y; Adachi S
Haematologica. 2015 Mar;100(3):e116-7., Mar. 2015, Peer-reviewed, Lead author

EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.
Matsuo H; Kajihara M; Tomizawa D; Watanabe T; Saito AM; Fujimoto J; Horibe K; Kodama K; Tokumasu M; Itoh H; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Shiba N; Ohki K; Hayashi Y; Yamashita Y; Shimada A; Tanaka S; Adachi S
Haematologica. 2014 Nov;99(11):e225-7., Nov. 2014, Peer-reviewed, Lead author

Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
Br J Haematol. 2014 Oct;167(1):80-6., Oct. 2014, Peer-reviewed

Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Kajihara M; Tomizawa D; Watanabe T; Saito AM; Fujimoto J; Horibe K; Kodama K; Tokumasu M; Itoh H; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Blood Cancer J. 2014 Jul 11;4(7):e226., Jul. 2014, Peer-reviewed, Lead author

Misc.

Introduce My Article
伊与田真寿; 松尾英将
臨床血液 66(2) 134, Feb. 2025, Invited

関節リウマチ診療に貢献する超音波検査
松尾英将, 藤井康友
日本臨床検査医学会誌 71(4) 230-235, Apr. 2023, Invited

Superb microvascular imaging(SMI)を用いた関節リウマチの再燃・寛解予測（第16回伊東賞受賞論文翻訳掲載）
松尾英将, 今村朱里, 清水円, 稲垣舞子, 辻侑子, 中坊周一郎, 橋本求, 伊藤宣, 田中司朗, 三森経世, 藤井康友
Jpn J Med Ultrasonics 49(6) 517-526, 2022, Invited

米国臨床検査技師の国際資格：ASCP International の最新情報 ―受験方法、出題内容から更新制度まで―
松尾英将
臨床検査学教育 14(1) 1-7, 2022, Invited

臨床検査技師のための研究入門原著論文の基本的な書きかた
松尾英将
検査と技術 (医学書院), 2020, Invited

臨床検査技師のための研究入門論文を投稿しよう！
松尾英将
検査と技術 (医学書院), 2020, Invited

AML治療におけるCDK4/6阻害薬の作用機序と有効性
松尾英将
血液内科 (科学評論社), 2020, Invited

Introduce My Article
松尾英将
臨床血液, 2019, Invited

国際学会に行こう！「はじめてで不安」「英語に自信がない」というあなたのために第3回発表をしよう！＜準備編＞
松尾英将
Medical Technology (医歯薬出版), 2016, Invited

国際学会に行こう！「はじめてで不安」「英語に自信がない」というあなたのために第4回発表をしよう！＜当日編＞
松尾英将
Medical Technology (医歯薬出版), 2016, Invited

Special Report 第32回世界医学検査学会国際学生フォーラム
大﨑博之; 菊地良介; 松尾英将; 岡田光貴; 井垣歩; 坂本秀生
Medical Technology (医歯薬出版), 2016, Invited

「遺伝子分析科学認定士制度」第5回一級認定試験を受験・合格して
松尾英将
日本臨床検査同学院通信, 2016, Invited

小児急性骨髄性白血病の分子的理解と臨床応用
松尾英将; 足立壯一
血液フロンティア (医薬ジャーナル社), 2016, Invited

造血器腫瘍の発症、治療におけるオートファジーの意義
松尾英将; 足立壯一
血液内科 (科学評論社), 2015, Invited

今知りたい臨床検査技師の国際資格制度：ASCP International Certification―最新情報から受験体験記まで―
松尾英将; 坂本秀生
Medical Technology (医歯薬出版), 2015, Invited

人間健康科学を学んで
松尾英将
京都大学大学案内「知と自由への誘い 2014」, 2014, Invited

アメリカ臨床検査技師の国際資格International Medical Technologist, MT(ASCPi)取得に挑戦して
松尾英将
京都大学大学院医学研究科人間健康科学系専攻紀要 : 健康科学 : health science, 2014, Invited

米国臨床検査技師の国際資格:International Medical Technologist, MT(ASCPi)を取得して
松尾英将
THE MEDICAL & TEST JOURNAL (じほう), 2013, Invited

DISCアポトーシス複合体によるネクローシス抑制
松尾英将; 足立壯一
血液内科 (科学評論社), 2012, Invited

Presentations

Interdisciplinary Collaboration for Promoting Research and Education in Medical Laboratory Science
Hidemasa Matsuo
8th Congress of Asia Association of Medical Laboratory Scientists (AAMLS), Apr. 2025, Invited

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia
Kota Shoji, Kenichi Yoshida, Shinju Iyoda, Moe Ishikawa, Miu Tanaka, Michidai Nobe, Yasuhito Nannya, Genki Yamato, Shinichi Tsujimoto, Norio Shiba, Yasuhide Hayashi, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Hiroshi Moritake, Akio Tawa, Junko Takita, Momoko Nishikori, Seishi Ogawa, Souichi Adachi, Hidemasa Matsuo
8th Congress of Asia Association of Medical Laboratory Scientists (AAMLS), Apr. 2025

小児急性骨髄性白血病の予後因子解析
松尾英将
第22回京滋血液腫瘍懇話会, Mar. 2025, Invited

The clinical impact and functional effects of concurrent FLT3-ITD and CCND3 mutations in acute myeloid leukemia
Kota Shoji, Kenichi Yoshida, Yasuhito Nannya, Genki Yamato, Shinichi Tsujimoto, Norio Shiba, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Junko Takita, Momoko Nishikori, Souichi Adachi, Seishi Ogawa, Hidemasa Matsuo
第66回日本小児血液・がん学会学術集会, Dec. 2024

急性骨髄性白血病の髄外浸潤におけるCCR1の役割
田中美羽、庄子皓太、伊与田真寿、石川百恵、宮原由佳、野邊道大、河下咲紀、陣内慶大、平田勝啓、三上貴司、加藤格、柴徳生、富澤大輔、多賀崇、滝田順子、錦織桃子、足立壯一、松尾英将
第71回日本臨床検査医学会学術集会, Nov. 2024

Concurrent FLT3-ITD and CCND3 mutations are linked to poor prognosis and drug resistance in AML
Kota Shoji, Kenichi Yoshida, Shinju Iyoda, Miu Tanaka, Moe Ishikawa, Michidai Nobe, Saki Kawashita, Yasuhito Nannya, Genki Yamato, Shinichi Tsujimoto, Norio Shiba, Yasuhide Hayashi, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Junko Takita, Momoko Nishikori, Souichi Adachi, Seishi Ogawa, Hidemasa Matsuo
第86回日本血液学会学術集会, Oct. 2024

Landscape of somatic mutations and their clinical impact on myeloid leukemia of Down syndrome
Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki, ..., Hidemasa Matsuo, Souichi Adachi, Yasuhide Hayashi, Takashi Taga, Akiko M. Saito, Keizo Horibe, Kenichiro Watanabe, Daisuke Tomizawa, Satoru Miyano, Satoru Takahashi, Seishi Ogawa, Etsuro Ito
第86回日本血液学会学術集会, Oct. 2024

Therapeutic and prognostic implications of driver mutations in KMT2A-rearranged acute myeloid leukemia
Hidemasa Matsuo
日本医療検査科学会第56回大会国際交流シンポジウム3: Young Scientists Symposium, Oct. 2024, Invited

ASCP Internationalの受験に向けて
松尾英将
第73回日本医学検査学会特別企画シンポジウム4, May 2024, Invited

国際資格・国際学会で広がる臨床検査技師活躍の舞台
松尾英将
日本医療検査科学会第38回春季セミナーシンポジウム I, Apr. 2024, Invited

Suppression of Super-Enhancer-Driven TAL1 Expression By KLF4 in T-Cell Acute Lymphoblastic Leukemia.
Mina Noura, Takahiko Yasuda, Shinobu Tsuzuki, Hidemasa Matsuo, Hitoshi Kiyoi, Fumihiko Hayakawa
65th ASH Annual Meeting & Exposition, Dec. 2023

Label-Free Cell Detection of Acute Leukemia Using High-Content Morphological Profiling in Flow.
Yoko Kawamura, Kayoko Nakanishi, Yuri Murata, Kazuki Teranishi, Ryusuke Miyazaki, Keisuke Toda, Toru Imai, Yasuhiro Kajiwara, Keiji Nakagawa, Hidemasa Matsuo, Souichi Adachi, Sadao Ota, Hidefumi Hiramatsu
65th ASH Annual Meeting & Exposition, Dec. 2023

KRAS codon G12 mutation as an adverse prognostic factor in pediatric KMT2A-rearranged AML.
Shinju Iyoda, Hidemasa Matsuo, Kenichi Yoshida, Nana Ito, Yasuhito Nannya, Genki Yamato, Norio Shiba, Yasuhide Hayashi, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Junko Takita, Momoko Nishikori, Seishi Ogawa, Souichi Adachi
第85回日本血液学会学術集会, Oct. 2023

Differences in mutational landscape and prognosis between infant and childhood KMT2A-rearranged AML.
Nana Ito, Hidemasa Matsuo, Kenichi Yoshida, Shinju Iyoda, Yasuhito Nannya, Genki Yamato, Norio Shiba, Yasuhide Hayashi, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Junko Takita, Momoko Nishikori, Seishi Ogawa, Souichi Adachi
第85回日本血液学会学術集会, Oct. 2023

Distinctive clonal evolution pattern and prognostic significance of the clonality of KRAS mutations in KMT2A-rearranged acute myeloid leukemia.
Hidemasa Matsuo, Kenichi Yoshida, Yasuhito Nannya, Yuri Ito, Aina Inagami, Nana Ito, Shinju Iyoda, Shoji Saito, Yuhki Koga, Hiroshi Moritake, Kiminori Terui, Koji Kawaguchi, Yasuhiro Okamoto, Hideki Nakayama, Miyako Kanno, Moeko Hino, Yusuke Akane, Akiko Inoue, Akira Shimada, Hiroaki Goto, Hiroo Ueno, Junko Takita, Genki Yamato, Norio Shiba, Yasuhide Hayashi, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Seishi Ogawa, Souichi Adachi
EHA2023 Hybrid Congress, Jun. 2023

関節リウマチ診療に貢献する超音波検査
松尾英将、藤井康友
第69回日本臨床検査医学会学術集会特別シンポジウム, Nov. 2022, Invited

Effects of benzimidazole anthelmintics on the differentiation of acute myeloid leukemia cells.
Aina Inagami, Hidemasa Matsuo, Nana Ito, Yutarou Harata, Moe Higashitani, Yuri Ito, Mina Noura, Souichi Adachi
第84回日本血液学会学術集会, Oct. 2022

Frequent formation of granulocytic sarcoma in NOD/Shi-scid IL2rgamma(null) mice transplanted with THP-1 cells.
Nana Ito, Hidemasa Matsuo, Yutarou Harata, Aina Inagami, Moe Higashitani, Yuri Ito, Masahiro Hirata, Keita Jinnouchi, Takashi Mikami, Itaru Kato, Souichi Adachi
第84回日本血液学会学術集会, Oct. 2022

Albendazole Mediates Monocytic Differentiation of Acute Myeloid Leukemia Cells by Stimulating the KLF4-DPYSL2A Axis.
Mina Noura, Ken Morita, Hiroki Kiyose, Yukiko Okuno, Hidemasa Matsuo, Asami Koyama, Yoko Nishinaka-Arai, Yasuhiko Kamikubo, Souichi Adachi
第44回日本分子生物学会年会, Dec. 2021

Clonal evolution pattern and prognostic significance of clonal architecture in KMT2A-rearranged acute myeloid leukemia.
Hidemasa Matsuo, Kenichi Yoshida, Yasuhito Nannya, Yuri Ito, Shoji Saito, Yuhki Koga, Hiroshi Moritake, Kiminori Terui, Koji Kawaguchi, Yasuhiro Okamoto, Hideki Nakayama, Kanno Miyako, Moeko Hino, Yusuke Akane, Akiko Inoue, Akira Shimada, Hiroaki Goto, Hiroo Ueno, Junko Takita, Genki Yamato, Norio Shiba, Yasuhide Hayashi, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Seishi Ogawa, Souichi Adachi
63rd ASH Annual Meeting & Exposition, Dec. 2021

MLL再構成急性骨髄性白血病におけるクローン進化機構の解析
伊東優里、松尾英将、吉田健一、南谷泰仁、原田優太郎、東谷萌絵、稲上愛菜、伊藤菜々、白石友一、宮野悟、富澤大輔、多賀崇、小川誠司、足立壯一
第68回日本臨床検査医学会学術集会, Nov. 2021

The importance of RUNX-NFAT axis as a novel therapeutic target for AML and GVHD.
Tatsuya Masuda, Hirohito Kubota, Kana Furuichi, Naoya Sakuramoto, Asuka Hada, Ayaka Horiuchi, Asami Sasaki, Kanako Takeda, Mizuho Takeda, Hidemasa Matsuo, Masahiro Hirata, Yoichi Imai, Tatsutoshi Nakahata, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
第83回日本血液学会学術集会, Sep. 2021

Clonal architecture and its prognostic significance in KMT2A-rearranged acute myeloid leukemia.
Hidemasa Matsuo, Kenichi Yoshida, Yasuhito Nannya, Yasuhiko Kamikubo, Shoji Saito, Yuhki Koga, Hiroshi Moritake, Kiminori Terui, Koji Kawaguchi, Yasuhiro Okamoto, Hideki Nakayama, Miyako Kanno, Moeko Hino, Yusuke Akane, Akiko Inoue, Akira Shimada, Hiroaki Goto, Hiroo Ueno, Junko Takita, Genki Yamato, Norio Shiba, Yasuhide Hayashi, Yuichi Shiraishi, Satoru Miyano, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Seishi Ogawa, Souichi Adachi
第83回日本血液学会学術集会, Sep. 2021

In vivo efficacy of CDK4/6 and autophagy inhibition on t(8;21) acute myeloid leukemia.
Yutarou Harata, Hidemasa Matsuo, Moe Higashitani, Kana Nakatani, Yuri Ito, Yasuhiko Kamikubo, Souichi Adachi
第83回日本血液学会学術集会, Sep. 2021

Development of a novel single cell sequencing method from blood smears and pathological specimens.
Moe Higashitani, Hidemasa Matsuo, Yutarou Harata, Yuri Ito, Aina Inagami, Nana Ito, Norimitsu Uza, Masahiro Shiokawa, Masashi Kanai, Manabu Muto, Souichi Adachi
第80回日本癌学会学術総会, Sep. 2021

新型コロナ禍の血液学実習における細胞鑑別e-learningソフト(Web PRO)の使用経験
松尾英将、中西加代子、西山有紀子、足立壯一
第15回日本臨床検査学教育学会学術大会, Aug. 2021

The RUNX Category in Hematological Malignancies.
Tatsuya Masuda, Hirohito Kubota, Naoya Sakuramoto, Asuka Hada, Ayaka Horiuchi, Hidemasa Matsuo, Masahiro Hirata, Yoichi Imai, Tatsutoshi Nakahata, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
The 12th JSH International Symposium in Kamakura, May 2021

KRAS mutations Frequently Coexist with High-Risk MLL Fusions and Are Independent Adverse Prognostic Factors in MLL-Rearranged Acute Myeloid Leukemia.
Hidemasa Matsuo; Kenichi Yoshida; Kana Nakatani; Yutarou Harata; Moe Higashitani; Yuri Ito; Yasuhiko Kamikubo; Yusuke Shiozawa; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Ai Okada; Yasuhito Nannya; June Takeda; Hiroo Ueno; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Akio Tawa; Satoru Miyano; Manja Meggendorfer; Claudia Haferlach; Seishi Ogawa; Souichi Adachi
62nd ASH Annual Meeting & Exposition, Dec. 2020

RUNX-NFAT Axis As a Novel Therapeutic Target for AML and T Cell Immunity.
Tatsuya Masuda; Hirohito Kubota; Naoya Sakuramoto; Asuka Hada; Ayaka Horiuchi; Asami Sasaki; Kanako Takeda; Mizuho Takeda; Hidemasa Matsuo; Hiroshi Sugiyama; Souichi Adachi; Yasuhiko Kamikubo
62nd ASH Annual Meeting & Exposition, Dec. 2020

Autophagy Inhibition Enhances CDK4/6 Inhibitor-Induced Apoptosis in t(8;21) Acute Myeloid Leukemia Cells.
Kana Nakatani; Hidemasa Matsuo; Yutarou Harata; Moe Higashitani; Asami Koyama; Mina Noura; Yoko Nishinaka-Arai; Yasuhiko Kamikubo; Souichi Adachi
62nd ASH Annual Meeting & Exposition, Dec. 2020

関節超音波検査・血液検査データを組み合わせた機械学習による関節リウマチの再燃予測
松尾英将; 青木沙央梨; 橋本求; 伊藤宣; 松田秀一; 鎌田真由美; 藤井康友
第93回日本超音波医学会学術集会, Dec. 2020

関節リウマチ患者の深寛解評価における関節超音波検査の有用性
松尾英将; 行松理紗子; 田淵裕也; 今村朱里; 橋本求; 伊藤宣; 藤井康友
第67回日本臨床検査医学会学術集会, Nov. 2020

2種のDopplerモードとそれらのgain変化の比較による臨床的寛解RA患者の手指関節評価法最適化の検討
今村朱里; 田淵裕也; 橋本求; 松尾英将; 藤井康友
第67回日本臨床検査医学会学術集会, Nov. 2020

血液塗抹標本と病理標本を用いた新規シングルセルシークエンス技術の確立
東谷萌絵; 松尾英将; 原田優太郎; 中谷香菜; 伊東優里; 平田勝啓; 片岡竜貴; 上久保靖彦; 足立壯一
第52回日本医療検査科学会, Oct. 2020

Thioredoxin interacting protein induces growth arrest and autophagy in mixed-lineage leukemia-rearranged acute myeloid leukemia cells.
Mina Noura; Hidemasa Matsuo; Asami Koyama; Souichi Adachi; Hiroshi Masutani
第79回日本癌学会学術総会, Oct. 2020

Examination of the importance of RUNX category in EGFR wild-type non-small cell lung cancer.
Atsushi Kobayakawa; Kanako Takeda; Tatsuya Masuda; Yohei Yanagida; Natsuno Obi; Naoya Sakuramoto; Asuka Hada; Ayaka Horiuchi; Mizuho Takeda; Asami Sasaki; Hidemasa Matsuo; Hiroshi Sugiyama; Souichi Adachi; Yasuhiko Kamikubo
第79回日本癌学会学術総会, Oct. 2020

Novel therapeutic strategy for Kras mutated colorectal cancer and PDAC.
Natsuno Obi; Mizuho Takeda; Tatsuya Masuda; Yohei Yanagida; Atsushi Kobayakawa; Naoya Sakuramoto; Asuka Hada; Ayaka Horiuchi; Asami Sasaki; Kanako Takeda; Hidemasa Matsuo; Souichi Adachi; Yasuhiko Kamikubo
第79回日本癌学会学術総会, Oct. 2020

RUNX-NFAT axis as a novel therapeutic target for AML and T cell immunity.
Tatsuya Masuda; Hirohito Kubota; Naoya Sakuramoto; Asuka Hada; Ayaka Horiuchi; Asami Sasaki; Kanako Takeda; Mizuho Takeda; Hidemasa Matsuo; Hiroshi Sugiyama; Souichi Adachi; Yasuhiko Kamikubo
第79回日本癌学会学術総会, Oct. 2020

Multiple regulation of FGFR signaling through CROX (Cluster regulation of RUNX) in DNPC.
Yohei Yanagida; Asami Sasaki; Tatsuya Masuda; Natsuno Obi; Atsushi Kobayakawa; Naoya Sakuramoto; Asuka Hada; Ayaka Horiuchi; Mizuho Takeda; Kanako Takeda; Hidemasa Matsuo; Hiroshi Sugiyama; Souichi Adachi; Yasuhiko Kamikubo
第79回日本癌学会学術総会, Oct. 2020

Identification of KRAS mutations as novel adverse prognostic factors in MLL-rearranged AML.
Hidemasa Matsuo; Kenichi Yoshida; Kana Nakatani; Yutarou Harata; Moe Higashitani; Yasuhiko Kamikubo; Yusuke Shiozawa; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Ai Okada; Yasuhito Nannya; June Takeda; Hiroo Ueno; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Akio Tawa; Satoru Miyano; Seishi Ogawa; Souichi Adachi
第82回日本血液学会学術集会, Oct. 2020

Philadelphia染色体陽性ALL：CROX(Cluster Regulation of RUNX)法によるBCR-ABL転写制御戦略
増田達哉; 窪田博仁; 立田俊也; 松尾英将; 杉山弘; 足立壯一; 上久保靖彦
第39回京都がん研究会, Sep. 2020

ドットダイセクションを用いた血液塗抹標本からのシングルセルシークエンス法の確立
原田優太郎; 松尾英将; 東谷萌絵; 中谷香菜; 上久保靖彦; 足立壯一
第21回日本検査血液学会学術集会, Jul. 2020

Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A/2B Copy Number Alterations.
Yusuke Hara; Tomohiko Taki; Genki Yamato; Kenichi Yoshida; Yusuke Shiozawa; Norio Shiba; Taeko Kaburagi; Yuichi Shiraishi; Kentaro Ohki; Machiko Kawamura; Manabu Sotomatsu; Hirokazu Arakawa; Hidemasa Matsuo; Akira Shimada; Tsutomu Toki; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Etsuro Ito; Keizo Horibe; Satoru Miyano; Seishi Ogawa; Souichi Adachi; Yasuhide Hayashi
61st ASH Annual Meeting & Exposition, Dec. 2019

Recurrent gene mutations in pediatric AML patients by targeted sequencing ―the JCCG study, JPLSG AML-05―.
Taeko Kaburagi; Genki Yamato; Norio Shiba; Kenichi Yoshida; Yusuke Hara; Yuichi Shiraishi; Kentaro Ohki; Manabu Sotomatsu; Hirokazu Arakawa; Hidemasa Matsuo; Akira Shimada; Tomohiko Taki; Nobutaka Kiyokawa; Daisuke Tomizawa; Keizo Horibe; Satoru Miyano; Takashi Taga; Souichi Adachi; Seishi Ogawa; Yasuhide Hayashi
61st ASH Annual Meeting & Exposition, Dec. 2019

Coexistence and prognostic significance of EVI1 expression and driver mutations in KMT2A-rearranged acute myeloid leukemia.
Hidemasa Matsuo; Kenichi Yoshida; Kana Nakatani; Yasuhiko Kamikubo; Daisuke Tomizawa; Takashi Taga; Nobutaka Kiyokawa; Seishi Ogawa; Manja Meggendorfer; Claudia Haferlach; Souichi Adachi
61st ASH Annual Meeting & Exposition, Dec. 2019

関節リウマチ患者の予後予測に最適な関節エコー検査部位およびカットオフ値の検討
松尾英将; 今村朱里; 清水円; 中坊周一郎; 橋本求; 伊藤宣; 藤井康友
第66回日本臨床検査医学会学術集会, Nov. 2019

Clinical significances of patients with KMT2C and PHF6 mutations in pediatric acute myeloid leukemia.
Taeko Kaburagi; Genki Yamato; Norio Shiba; Kenichi Yoshida; Yusuke Hara; Yuichi Shiraishi; Kentaro Ohki; Manabu Sotomatsu; Hirokazu Arakawa; Hidemasa Matsuo; Akira Shimada; Tomohiko Taki; Nobutaka Kiyokawa; Daisuke Tomizawa; Keizo Horibe; Satoru Miyano; Souichi Adachi; Takashi Taga; Seishi Ogawa; Yasuhide Hayashi
第61回日本小児血液・がん学会学術集会, Nov. 2019

Clinical and molecular characterization of pediatric acute myeloid leukemia with TP53 alterations.
Yusuke Hara; Tomohiko Taki; Genki Yamato; Kenichi Yoshida; Norio Shiba; Taeko Kaburagi; Yuichi Shiraishi; Kentaro Ohki; Machiko Kawamura; Manabu Sotomatsu; Hirokazu Arakawa; Hidemasa Matsuo; Akira Shimada; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Keizo Horibe; Satoru Miyano; Seishi Ogawa; Souichi Adachi; Yasuhide Hayashi
第61回日本小児血液・がん学会学術集会, Nov. 2019

CDK4/6 and autophagy inhibitors synergistically induce apoptosis in t(8;21) AML cells.
Kana Nakatani; Hidemasa Matsuo; Yuki Morimoto; Yasuhiko Kamikubo; Souichi Adachi
第81回日本血液学会学術集会, Oct. 2019

Recurrent gene mutations in pediatric AML by targeted sequencing using a 343-gene custom panel.
Taeko Kaburagi; Genki Yamato; Norio Shiba; Kenichi Yoshida; Yusuke Hara; Yuichi Shiraishi; Kentaro Ohki; Manabu Sotomatsu; Hirokazu Arakawa; Hidemasa Matsuo; Akira Shimada; Tomohiko Taki; Nobutaka Kiyokawa; Daisuke Tomizawa; Keizo Horibe; Satoru Miyano; Souichi Adachi; Takashi Taga; Seishi Ogawa; Yasuhide Hayashi
第81回日本血液学会学術集会, Oct. 2019

小児MLL再構成急性骨髄性白血病(AML)の網羅的遺伝子解析による新規予後因子同定
松尾英将; 吉田健一; 中谷香菜; 上久保靖彦; 小川誠司; 足立壯一
第38回京都がん研究会, Oct. 2019

Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells.
能浦三奈; 森田剣; 清瀬大樹; 立田俊也; 松尾英将; 上久保靖彦; 足立壯一
第78回日本癌学会学術総会, Sep. 2019

KIT regulator "RUNX1" as a novel therapeutic target in human mast-cell diseases.
増田達哉; 片岡竜貴; 立田俊也; 松尾英将; 杉山弘; 足立壯一; 上久保靖彦
第78回日本癌学会学術総会, Sep. 2019

Targeting RUNX1-TRIM24/BCL11A axis through CROX (Cluster Regulation of RUNX) as a therapeutic strategy for neuroblastoma.
小林紫乃; 佐々木亜沙美; 沖中えり佳; 武田佳那子; 武田瑞穂; 松尾英将; 野口勇貴; 杉山弘; 足立壯一; 上久保靖彦
第78回日本癌学会学術総会, Sep. 2019

The combinatorial Histone Acetyltransferases (HATs) inhibition as a novel therapeutic strategy for KRAS enhanced cancers.
沖中えり佳; 小林紫乃; 武田瑞穂; 佐々木亜沙美; 武田佳那子; 松尾英将; 足立壯一; 上久保靖彦
第78回日本癌学会学術総会, Sep. 2019

The importance of pan-RUNX and CROX (Cluster Regulation of RUNX) therapeutic approach for gastrointestinal cancers.
武田瑞穂; 沖中えり佳; 小林紫乃; 割石菜月; 佐々木亜沙美; 武田佳那子; 松尾英将; 杉山弘; 足立壯一; 上久保靖彦
第78回日本癌学会学術総会, Sep. 2019

Apoptotic cell death induced by p300/CBPSurvivin regulation in triple negative breast cancer.
割石菜月; 田中直; 川口展子; 沖中えり佳; 小林紫乃; 佐々木亜沙美; 武田瑞穂; 武田佳那子; 松尾英将; 足立壯一; 上久保靖彦
第78回日本癌学会学術総会, Sep. 2019

Induction of cell death in Malignant rhabdoid tumor (MRT) cells through regulating RUNX-Survivin Axis.
三上真充; 沖中えり佳; 大封智雄; 金谷卓弥; 小林紫乃; 服部悦子; 松井恭澄; 松尾英将; 杉山弘; 足立壯一; 上久保靖彦
第78回日本癌学会学術総会, Sep. 2019

Identification of RUNX1-NFATc2 axis as a novel target for overcoming drug-resistant APL.
立田俊也; 古市華菜; 増田達哉; 窪田博仁; 岩井篤; 三上真充; 服部悦子; 松尾英将; 杉山弘; 足立壯一; 上久保靖彦
第78回日本癌学会学術総会, Sep. 2019

Induction of autophagy by CDK4/6 inhibition in t(8;21) acute myeloid leukemia cells.
中谷香菜; 松尾英将; 上久保靖彦; 足立壯一
第78回日本癌学会学術総会, Sep. 2019

「疑似髄液」による細胞数算定検査の学内実習の試み
徳野治; 松尾英将; 上久保靖彦; 藤井康友; 足立壯一; 杉本直三
第14回日本臨床検査学教育学会学術大会, Aug. 2019

ddPCRを用いた小児APLの微小残存病変の解析：AML-P17付随研究
松尾英将; 湯坐有希; 高橋浩之; 富澤大輔; 多賀崇; 足立壯一
2019年度第１回JCCG血液腫瘍分科会（JPLSG）全体会議・合同班会議, Jun. 2019

関節リウマチ患者の再燃予測に有用な関節エコー検査部位の探索
今村朱里; 松尾英将; 田淵裕也; 清水円; 稲垣舞子; 辻侑子; 橋本求; 伊藤宣; 藤井康友
第92回日本超音波医学会学術集会, May 2019

Recurrent genomic aberrations of D-type cyclins are therapeutic targets of CDK4/6 inhibitors in t(8;21) and MLL-rearranged acute myeloid leukemia.
Hidemasa Matsuo; Kenichi Yoshida; Kazutaka Fukumura; Kana Nakatani; Yuki Noguchi; Saho Takasaki; Mina Noura; Yusuke Shiozawa; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Ai Okada; Yasuhito Nannya; June Takeda; Hiroo Ueno; Norio Shiba; Genki Yamato; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Akio Tawa; Yasuhide Hayashi; Hiroyuki Mano; Satoru Miyano; Yasuhiko Kamikubo; Seishi Ogawa; Souichi Adachi
60th ASH Annual Meeting and Exposition, Dec. 2018

Comprehensive Analysis of 343 Genes Using Targeted Sequencing Panel By Next-Generation Sequencer in 77 Pediatric AML Patients with Normal and Complex Karyotypes: Jccg Study, JPLSG AML-05.
Taeko Kaburagi; Genki Yamato; Norio Shiba; Kenichi Yoshida; Yusuke Hara; Yuichi Shiraishi; Kentaro Ohki; Manabu Sotomatsu; Hirokazu Arakawa; Hidemasa Matsuo; Akira Shimada; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Keizo Horibe; Satoru Miyano; Seishi Ogawa; Souichi Adachi; Yasuhide Hayashi
60th ASH Annual Meeting and Exposition, Dec. 2018

The detection of minor clones with somatic KIT D816V mutations in pediatric de novo AML
Koji Sasaki; Norio Shiba; Yuri Uchiyama; Junji Ikeda; Masahiro Yoshitomi; Yuko Shimosato; Mayu Tokumasu; Hidemasa Matsuo; Kenichi Yoshida; Kentaro Ohki; Genki Yamato; Yusuke Hara; Akitoshi Kinoshita; Daisuke Tomizawa; Takashi Taga; Souichi Adachi; Akio Tawa; Keizo Horibe; Naomichi Matsumoto; Shuichi Ito; Yasuhide Hayashi
第80回日本血液学会学術集会, Oct. 2018

Identification of recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.
Hidemasa Matsuo; Kenichi Yoshida; Kazutaka Fukumura; Yuki Noguchi; Saho Takasaki; Mina Noura; Yusuke Shiozawa; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Ai Okada; Yasuhito Nannya; June Takeda; Hiroo Ueno; Norio Shiba; Genki Yamato; Hiroshi Handa; Yuichiro Ono; Nobuhiro Hiramoto; Takayuki Ishikawa; Kensuke Usuki; Ken Ishiyama; Shuichi Miyawaki; Hidehiro Itonaga; Yasushi Miyazaki; Machiko Kawamura; Hiroki Yamaguchi; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Akio Tawa; Yasuhide Hayashi; Hiroyuki Mano; Satoru Miyano; Yasuhiko Kamikubo; Seishi Ogawa; Souichi Adachi
第80回日本血液学会学術集会, Oct. 2018

Landscape and prognostic significance of coexisting mutations in pediatric MLL-rearranged AML.
Hidemasa Matsuo; Kenichi Yoshida; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Hiroo Ueno; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Akio Tawa; Satoru Miyano; Yasuhiko Kamikubo; Seishi Ogawa; Souichi Adachi
The 33rd World Congress of Biomedical Laboratory Science (IFBLS), Sep. 2018

小児AMLにおけるG-CSFR isoform IV発現解析
松尾英将; 上久保靖彦; 足立壯一
第13回京都地区小児血液腫瘍研究会, Jul. 2018

Cell-autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells
Mina Noura; Ken Morita; Chieko Tokushige; Shintaro Maeda; Hiroki Kiyose; Toshikazu Bando; Kenichi Yoshida; Hidemasa Matsuo; Seishi Ogawa; Paul P. Liu; Hiroshi Sugiyama; Souichi Adachi; Yasuhiko Kamikubo
59th ASH Annual Meeting & Exposition, Dec. 2017

RUNX cluster regulation by GENE SWITCH triggers a profound tumor regression of diverse origins
Ken Morita; Kensho Suzuki; Shintaro Maeda; Yoshihide Mitsuda; Chieko Tokushige; Gengo Kashiwazaki; Junichi Taniguchi; Rina Maeda; Mina Noura; Masahiro Hirata; Tatsuki Kataoka; Hiroki Kiyose; Mayu Tokumasu; Hidemasa Matsuo、Akihiko
第79回日本血液学会学術集会, Oct. 2017

特発性びまん性肺骨形成の1例
小松貴義; 徳田深作; 半田知宏; 土谷美知子; 久保武; 吉澤明彦; 山本裕子; 池添浩平; 中塚賀也; 松尾英将; 中山祐子; 志賀修一; 人見健文; 足立壮一; 一山智; 陳和夫; 伊達洋至; 平井豊博
平成29年度NPO夏季学術集会, Jul. 2017

Distribution of the driver mutations among blood cell compartments in MDS and AML
Hidemasa Matsuo; Hiroo Ueno; Kenichi Yoshida; Yuichi Shiraishi; Hiroko Tanaka; Kenichi Chiba; Tomohiro Wakita; Katsuyuki Ohmori; Hidefumi Hiramatsu; Hiroshi Kawabata; Akifumi Takaori-Kondo; Yasuhiko Kamikubo; Satoru Miyano; Seishi Ogawa; Souichi Adachi
第78回日本血液学会学術集会, Oct. 2016

Experience of the first certification of ISO15189:2012 in physiological examination in Japan
Hidemasa Matsuo; Kanako Suzuki; Kuniko Iwata; Tomoya Yoneda; Yuko Nakayama; Takeshi Higuchi; Shuichi Shiga; Satoshi Ichiyama
The 32nd World Congress of Biomedical Laboratory Science (IFBLS), Aug. 2016

法的脳死判定における脳波検査および聴性脳幹誘発電位検査の経験
小川真実; 鈴木加奈子; 梶田久美; 小島隼; 山本将司; 松尾英将; 岡村友美子; 中山祐子; 人見健文; 池田昭夫; 志賀修一; 一山智
平成28年度日臨技近畿支部医学検査学会, May 2016

Prognostic Significance of CXCR4 Overexpression in Pediatric Acute Myeloid Leukemia with Low-Risk: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group
Hidemasa Matsuo; Naomi Nakamura; Daisuke Tomizawa; Akiko M. Saito; Nobutaka Kiyokawa; Keizo Horibe; Yoko Nishinaka-Arai; Mayu Tokumasu; Hiroshi Itoh; Yasuhiko Kamikubo; Hideki Nakayama; Akitoshi Kinoshita; Takashi Taga; Akio Tawa; Tomohiko Taki; Shiro Tanaka; Souichi Adachi
57th ASH Annual Meeting and Exposition, Dec. 2015

Investigation of new cell surface markers in acute myeloid leukemia using multi-color flow cytometry
Tomohiro Wakita; Hidefumi Hiramatsu; Katsuyuki Ohmori; Hidemasa Matsuo; Emi Sugimoto; Souichi Adachi
第77回日本血液学会学術集会, Oct. 2015

Prognostic significance of CXCR4 overexpression in pediatric AML: the JPLSG AML-05 study
Hidemasa Matsuo; Naomi Nakamura; Daisuke Tomizawa; Tomoyuki Watanabe; Akiko Moriya Saito; Jun-ichro Fujimoto; Keizo Horibe; Yoko Nishinaka; Mayu Tokumasu; Hiroshi Itoh; Yasuhiko Kamikubo; Hideki Nakayama; Akitoshi Kinoshita; Takashi Taga; Akio Tawa; Tomohiko Taki; Souichi Adachi
第77回日本血液学会学術集会, Oct. 2015

ISO15189：2012 生理学的分野の拡大審査認定取得概要と今後の展望
鈴木加奈子; 中山祐子; 福山宏樹; 松尾英将; 梶田久美; 小川真美; 石川裕子; 岩田邦子; 米田智也; 人見健文; 中島康弘; 樋口武史; 志賀修一; 一山智
第58回日本臨床検査医学会近畿支部総会, Oct. 2015

世界の医療をリードする臨床検査技師を目指して
松尾英将
第64回日本医学検査学会若手技師セミナー, May 2015, Invited

A novel method to investigate prognostic factors by purifying leukemic blast cells from blood smears
Hidemasa Matsuo; Ayaka Ikeuchi; Shuichi Shiga; Hiroshi Itoh; Yasuhiko Kamikubo; Satoshi Ichiyama; Souichi Adachi
The 31st World Congress of Biomedical Laboratory Science (IFBLS), Oct. 2014

好中球の殺菌能におけるオートファジー機構の役割
伊藤洋志; 北村奈緒子; 山本翔; 松尾英将; 足立壯一
第25回日本生体防御学会学術総会, Jul. 2014

レーザーマイクロダイセクションを用いてスメア標本より純化した白血病細胞を用いた小児AMLの新規予後因子探索
松尾英将; 吉田健一; 中谷哲章; 児玉紅美; 志賀修一; 小川誠司; 足立壯一
平成26 年度第1 回合同班会議 JPLSG 総会・研究会, Jun. 2014

THE PROGNOSTIC RELEVANCE OF THE 2008 WHO CLASSIFICATION OF MYELOID NEOPLASMS IN CHILDHOOD ACUTE MYELOID LEUKEMIA
Akitoshi Kinoshita; Hayato Miyachi; Hiromichi Matsushita; Miharu Yabe; Tomohiko Taki; Tomoyuki Watanabe; Akiko M. Saito; Daisuke Tomizawa; Takashi Taga; Hiroyuki Takahashi; Hidemasa Matsuo; Kumi Kodama; Kentaro Ohki; Yasuhide Hayashi; Akio Tawa; Keizo Horibe; Souichi Adachi
19th Congress of the European Hematology Association, Jun. 2014

Investigation of the clinical significance of CEBPA mutation in child AML: the JPLSG AML-05 study
Hidemasa Matsuo; Mio Kajihara; Daisuke Tomizawa; Tomoyuki Watanabe; Akiko Moriya Saito; Jun-ichro Fujimoto; Keizo Horibe; Mayu Tokumasu; Hiroshi Itoh; Hideki Nakayama; Akitoshi Kinoshita; Takashi Taga; Akio Tawa; Tomohiko Taki; Souichi Adachi
第75回日本血液学会学術集会, Oct. 2013

血液疾患の予後因子をスメア標本より検出するシステムの確立
松尾英将; 池内絢香; 志賀修一; 土岐力; 照井君典; 伊藤悦朗; 足立壯一
第8回日本臨床検査学教育学会, Aug. 2013

感染症治療における好中球の殺菌能の意義とオートファジーの役割について
北村奈緒子; 松尾英将; 伊藤洋志; 近藤忠一; 足立壯一
第22回日本Cell Death学会, Jul. 2013

免疫グロブリン製剤による多剤耐性菌に対する好中球の殺菌能増強効果～移植後免疫抑制患者における検討～
北村奈緒子; 松尾英将; 伊藤洋志; 近藤忠一; 笹田昌孝; 足立壯一
第87回日本感染症学会総会学術集会, Jun. 2013

AML-D11付随研究：ダウン症候群に合併した急性骨髄性白血病(AML-DS)の新規予後因子探索
松尾英将; 池内絢香; 志賀修一; 土岐力; 照井君典; 伊藤悦朗; 足立壯一
平成25年度第1回JPLSG全体会議・合同班会議, Jun. 2013

AMLおよびMDSの新規予後因子探索プロジェクトについて
松尾英将; 志賀修一; 足立壯一
平成24年度第2回JPLSG全体会議・合同班会議, Nov. 2012

免疫グロブリン製剤による貪食刺激好中球のオートファジー増強とその役割
松尾英将; 伊藤洋志; 足立壯一
第21回日本Cell Death学会, Jul. 2012

好中球のオートファジーを介した多剤耐性菌殺菌機構と免疫グロブリン製剤による増強作用
松尾英将; 伊藤洋志; 笹田昌孝; 足立壯一
第86 回日本感染症学会総会学術集会, Apr. 2012

免疫グロブリン製剤による多剤耐性菌に対する好中球殺菌増強作用
松尾英将; 堀明日香; 伊藤洋志; 笹田昌孝; 足立壯一
第85回日本感染症学会総会学術集会, Apr. 2011

Industrial Property Rights

特願2024-047207, 白血病の髄外浸潤マーカー
松尾英将

Awards

24 Oct. 2015
米国血液学会, Abstract Achievement Award

14 Mar. 2016
京都大学, 京都大学総長賞

22 Feb. 2018
日本臨床衛生検査技師会, 日臨技学生表彰会長賞

27 Oct. 2018
日本白血病研究基金, 若手一般研究賞

04 Dec. 2020
日本超音波医学会, 第21回奨励賞

22 May 2021
日本超音波医学会, 第16回伊東賞

12 Nov. 2021
日本臨床検査医学会, 国際学会奨励賞

06 Feb. 2023
日本血液学会, JSH Travel Award for EHA Congress 2023

Media Coverage

AMLの治りやすさ正確に予測京大、遺伝子異常を発見
日刊工業新聞, 23面, 19 Apr. 2024

子どもの白血病遺伝子の特徴発見京大などチーム最適な治療選択可能に
読売新聞, 夕刊 10面, 18 Apr. 2024

MLL再構成の急性骨髄性白血病の予後を予測する新規マーカーを発見－京大ほか
医療ニュース QLifePro, http://www.qlifepro.com/news/20201007/mll-rearranged-aml.html, 07 Oct. 2020

白血病、既存の乳がん薬が効果京大が遺伝子変異特定
日経電子版, https://r.nikkei.com/article/DGXMZO37173800R31C18A0000000?s=3, 01 Nov. 2018

乳がん薬白血病抑える京大、細胞実験で確認
日本経済新聞, 朝刊42面, 01 Nov. 2018

External funds: Kakenhi

KMT2A再構成急性骨髄性白血病の新規検査技術確立とクローン構造解析
Grant-in-Aid for Scientific Research (C)
Basic Section 54010:Hematology and medical oncology-related
Kyoto University
松尾英将
From 01 Apr. 2022, To 31 Mar. 2026, Granted
急性骨髄性白血病;KMT2A;遺伝子変異;次世代シークエンス;再発;クローン進化;シングルセル
https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K08475/

Identification of D-type cyclin gene abnormalities and development of novel therapeutic strategies in pediatric acute myeloid leukemia
Grant-in-Aid for Early-Career Scientists
Basic Section 50020:Tumor diagnostics and therapeutics-related
Kyoto University
Hidemasa Matsuo
From 01 Apr. 2019, To 31 Mar. 2023, Discontinued
白血病;AML;遺伝子異常;t(8;21);CCND2;CDK4/6;オートファジー;急性骨髄性白血病;アポトーシス;次世代シークエンス;遺伝子変異;CCND
https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19K16832/

Investigation of novel prognostic factors in acute myeloid leukemia using the purification system of leukemic cells
Grant-in-Aid for Young Scientists (B)
Kyoto University
Hidemasa Matsuo
From 01 Apr. 2016, To 31 Mar. 2019, Project Closed
白血病;予後因子;レーザーマイクロダイセクション;次世代シークエンス;CXCR4;G-CSFR;CCND3;CDK4/6;MLL再構成;急性骨髄性白血病;遺伝子変異;遺伝子;次世代シーケンス
https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K19193/

Development of new therapy for refractory AML in children
Grant-in-Aid for Scientific Research (C)
Basic Section 52050:Embryonic medicine and pediatrics-related
Shiga General Hospital Clinical Research Center
足立壯一
From 01 Apr. 2023, To 31 Mar. 2026, Granted
急性骨髄性白血病;小児;再発;遺伝子異常;シークエンス
https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K07264/

External funds: others

KMT2A再構成急性骨髄性白血病のトランスクリプトーム解析に基づく治療法開発
日本血液学会 2022年度研究助成金
From 01 Apr. 2022, To 31 Mar. 2023
松尾英将

MLL再構成急性骨髄性白血病のクローン進化パターンの解明
日本血液学会 2021年度研究助成金
From 01 Apr. 2021, To 31 Mar. 2022
松尾英将

急性骨髄性白血病の新規分化誘導治療薬の探索
日本医療研究開発機構(AMED)　創薬ブースター(創薬総合支援事業)
From 01 Apr. 2021, To 31 Mar. 2024
松尾英将

血液塗抹標本および病理標本からのシングルセル遺伝子変異解析法の確立と応用
公益信託臨床検査医学研究振興基金
From 05 Feb. 2021, To 04 Feb. 2022
松尾英将

AML発症におけるMLL再構成とドライバー変異の協調メカニズムの解明
日本血液学会 2020年度研究助成金
From 01 Apr. 2020, To 31 Mar. 2021
松尾英将

血液腫瘍疾患のクローン構造解明に寄与する新規シングルセル解析法の確立
日本血液学会 2019年度研究助成金
From 01 Apr. 2019, To 31 Mar. 2020
松尾英将

小児急性骨髄性白血病におけるD-type Cyclin遺伝子の3’ UTR構造異常の解明
公益信託日本白血病研究基金助成金
From 27 Oct. 2018, To 30 Sep. 2019
松尾英将

網羅的遺伝子解析により同定したt(8;21)AMLの新規遺伝子変異をターゲットとした治療法開発
日本血液学会 2018年度研究助成金
From 01 Apr. 2018, To 31 Mar. 2019
松尾英将

正常核型急性骨髄性白血病における新規予後因子探索
公益財団法人黒住医学研究振興財団第25回研究助成金
From 01 Nov. 2017, To 31 Oct. 2018
松尾英将

小児MLL再構成AMLにおける新規遺伝子変異の機能解析および新規治療法開発
日本血液学会 2017年度研究助成金
From 01 Apr. 2017, To 31 Mar. 2018
松尾英将

Last Updated :2025/05/02

Education

Teaching subject(s)

From 01 Apr. 2024, To 31 Mar. 2025
Hematology II
8050, Fall, Faculty of Medicine, 1

From 01 Apr. 2024, To 31 Mar. 2025
Quality Control of Clinical Laboratory
8036, Fall, Faculty of Medicine, 1

From 01 Apr. 2024, To 31 Mar. 2025
Practice of Clinical Physiology and Diagnosis by Ultrasonogr
8034, Fall, Faculty of Medicine, 1

From 01 Apr. 2024, To 31 Mar. 2025
Immunology training
8032, Fall, Faculty of Medicine, 1

From 01 Apr. 2024, To 31 Mar. 2025
Practice of Hematology
8013, Spring, Faculty of Medicine, 1

From 01 Apr. 2024, To 31 Mar. 2025
Introduction to Human Health Sciences IV
3204, Fall, Faculty of Medicine, 1

From 01 Apr. 2024, To 31 Mar. 2025
Genomics Seminar
M436, Fall, Graduate School of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Pathophysiology
M044, Spring, Graduate School of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Clinical Medicine Lecture
M458, Spring, Graduate School of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Diagnostic Imaging Seminar
M442, Fall, Graduate School of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Clinical research and development studies seminar
M439, Fall, Graduate School of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Laboratory medicine practice
8051, Fall, Faculty of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Hematology I
8049, Spring, Faculty of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Practice of General Clinical Laboratory
8038, Spring, Faculty of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
General Clinical Examination
8037, Spring, Faculty of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Hematology
8012, Spring, Faculty of Medicine, 2

From 01 Apr. 2024, To 31 Mar. 2025
Learning Clinical Laboratory Medicine in Hospital
8043, Fall, Faculty of Medicine, 8

From 01 Apr. 2024, To 31 Mar. 2025
Special Seminar of Multidisciplinary Medical Sciences
M456, Year-long, Graduate School of Medicine, 8

From 01 Apr. 2024, To 31 Mar. 2025
Genomics Practice
M437, Year-long, Graduate School of Medicine, 4

From 01 Apr. 2023, To 31 Mar. 2024
Practice of Clinical Physiology and Diagnosis by Ultrasonogr
8034, Fall, Faculty of Medicine, 1

From 01 Apr. 2023, To 31 Mar. 2024
Practice of Hematology
8013, Spring, Faculty of Medicine, 1

From 01 Apr. 2023, To 31 Mar. 2024
Pathophysiology
M044, Spring, Graduate School of Medicine, 2

From 01 Apr. 2023, To 31 Mar. 2024
Diagnostic Imaging Seminar
M442, Fall, Graduate School of Medicine, 2

From 01 Apr. 2023, To 31 Mar. 2024
Clinical research and development studies seminar
M439, Fall, Graduate School of Medicine, 2

From 01 Apr. 2023, To 31 Mar. 2024
Practice of General Clinical Laboratory
8038, Spring, Faculty of Medicine, 2

From 01 Apr. 2023, To 31 Mar. 2024
Learning Clinical Laboratory Medicine in Hospital
8043, Fall, Faculty of Medicine, 8

From 01 Apr. 2021, To 31 Mar. 2022
Immunology I
Fall

From 01 Apr. 2022, To 31 Mar. 2023
Practice of General Clinical Laboratory
8038, Spring, Faculty of Medicine, 2

From 01 Apr. 2022, To 31 Mar. 2023
Clinical research and development studies advanced research
D439, Year-long, Graduate School of Medicine, 4

From 01 Apr. 2022, To 31 Mar. 2023
Practice of Clinical Physiology and Diagnosis by Ultrasonogr
8034, Fall, Faculty of Medicine, 1

From 01 Apr. 2022, To 31 Mar. 2023
Diagnostic Imaging Seminar
M442, Fall, Graduate School of Medicine, 2

From 01 Apr. 2022, To 31 Mar. 2023
Clinical research and development studies seminar
M439, Fall, Graduate School of Medicine, 2

From 01 Apr. 2022, To 31 Mar. 2023
Practice of Hematology
8013, Spring, Faculty of Medicine, 1

From 01 Apr. 2022, To 31 Mar. 2023
Learning Clinical Laboratory Medicine in Hospital
8043, Fall, Faculty of Medicine, 8

From 01 Apr. 2022, To 31 Mar. 2023
Clinical research and development studies advanced lecture
D437, Year-long, Graduate School of Medicine, 4

From 01 Apr. 2022, To 31 Mar. 2023
Pathophysiology
M044, Spring, Graduate School of Medicine, 2

From 01 Apr. 2022, To 31 Mar. 2023
Clinical research and development studies advanced seminar
D438, Year-long, Graduate School of Medicine, 4

From 01 Apr. 2018, To 31 Mar. 2019
Practice of Hematological Laboratory Medicine
Spring, 医学部（人間健康科学科）

From 01 Apr. 2018, To 31 Mar. 2019
Practice of General Clinical Laboratory
Spring, 医学部（人間健康科学科）

From 01 Apr. 2018, To 31 Mar. 2019
Pathophysiology
Spring, 医学研究科（人間健康科学系専攻）

From 01 Apr. 2018, To 31 Mar. 2019
Practice of Clinical Physiology and Diagnosis by Ultrasonogr
Fall, 医学部（人間健康科学科）

From 01 Apr. 2018, To 31 Mar. 2019
Introduction to Human Health Sciences IV
Fall, 医学部（人間健康科学科）

From 01 Apr. 2018, To 31 Mar. 2019
Practice of Biological Response Analysis
Fall, 医学部（人間健康科学科）

From 01 Apr. 2018, To 31 Mar. 2019
Immunology training
Fall, 医学部（人間健康科学科）

From 01 Apr. 2018, To 31 Mar. 2019
Practice of Informative Clinical Medicine
Fall, 医学部（人間健康科学科）

From Apr. 2019, To Mar. 2020
Immunology training
Fall, 医学部（人間健康科学科）

From Apr. 2019, To Mar. 2020
Pathophysiology
Spring, 医学研究科（人間健康科学系専攻）

From Apr. 2019, To Mar. 2020
Practice of Clinical Physiology and Diagnosis by Ultrasonogr
Fall, 医学部（人間健康科学科）

From Apr. 2019, To Mar. 2020
Practice of Informative Clinical Medicine
Fall, 医学部（人間健康科学科）

From Apr. 2019, To Mar. 2020
Practice of Hematology
Spring, 医学部（人間健康科学科）

From Apr. 2019, To Mar. 2020
Practice of General Clinical Laboratory
Spring, 医学部（人間健康科学科）

From Apr. 2020, To Mar. 2021
Pathophysiology
Spring, 医学研究科（人間健康科学系専攻）

From Apr. 2020, To Mar. 2021
Learning Clinical Laboratory Medicine in Hospital
Fall, 医学部（人間健康科学科）

From Apr. 2020, To Mar. 2021
Practice of General Clinical Laboratory
Spring, 医学部（人間健康科学科）

From Apr. 2020, To Mar. 2021
Practice of Clinical Physiology and Diagnosis by Ultrasonogr
Fall, 医学部（人間健康科学科）

From Apr. 2020, To Mar. 2021
Practice of Hematology
Spring, 医学部（人間健康科学科）

From Apr. 2021, To Mar. 2022
Pathophysiology
Spring, 医学研究科（人間健康科学系専攻）

From Apr. 2021, To Mar. 2022
Learning Clinical Laboratory Medicine in Hospital
Fall, 医学部（人間健康科学科）

From Apr. 2021, To Mar. 2022
Practice of General Clinical Laboratory
Spring, 医学部（人間健康科学科）

From Apr. 2021, To Mar. 2022
Practice of Clinical Physiology and Diagnosis by Ultrasonogr
Fall, 医学部（人間健康科学科）

From Apr. 2021, To Mar. 2022
Diagnostic Imaging Seminar
Fall, 医学研究科（人間健康科学系専攻）

From Apr. 2021, To Mar. 2022
Clinical research and development studies seminar
Fall, 医学研究科（人間健康科学系専攻）

From Apr. 2021, To Mar. 2022
Clinical research and development studies advanced research
Year-long, 医学研究科（人間健康科学系専攻）

From Apr. 2021, To Mar. 2022
Clinical research and development studies advanced lecture
Year-long, 医学研究科（人間健康科学系専攻）

From Apr. 2021, To Mar. 2022
Clinical research and development studies advanced seminar
Year-long, 医学研究科（人間健康科学系専攻）

From Apr. 2021, To Mar. 2022
Practice of Hematology
Spring, 医学部（人間健康科学科）

Student achievements: Awards

JACLaS Award 2020(優秀演題賞)
東谷萌絵, 日本医療検査科学会, 03 Sep. 2020

Part-time lecturer

From 01 Apr. 2021
臨床検査学
後期, 大阪人間科学大学, 保健医療学部

Last Updated :2025/05/02

Administration

Faculty management (title, position)

From 01 Apr. 2023, To 31 Mar. 2024
研究検討委員会委員

From 01 Apr. 2022, To 31 Mar. 2023
医学系研究管理委員会委員

From 01 Apr. 2018, To 31 Mar. 2019
多職種教育・合同教育TF

ページ上部へ戻る

Search for faculty members

Matuo, Hidemasa

Basic Information

Faculty

Email Address

Email Address

Professional Memberships

Academic Degree

Academic Resume (Undergraduate School/Majors)

High School

High School

Research History

Profile

Profile

ID,URL

J-Global ID

Researcher number

External link

Website(s) (URL(s))

researchmap URL

Research

Research Topics, Overview of the research

Research Topics

Overview of the research

Research Interests

Research Areas

Papers

Misc.

Presentations

Industrial Property Rights

Awards

Media Coverage

External funds: Kakenhi

External funds: others

Education

Teaching subject(s)

Student achievements: Awards

Part-time lecturer

Administration

Faculty management (title, position)

Academic, Social Contribution

Committee Memberships

Social Contribution